Research Proposals Being Accepted for PHenomenal Impact Fund
Deadline for submitting letters of intent is Feb. 14; winner notified in May
The PHenomenal Impact Fund for Global PH Research is accepting research proposals, according to a press release.
On its fifth year, Team PHenomenal Hope’s research fund will award up to $50,000 for 12 months for proposals that focus on new concepts in pulmonary hypertension (PH) that have the potential to change the field. The concept’s goals must be achievable within a year and within the time the award is allocated, according to the nonprofit’s webpage.
Applications are expected to demonstrate eventual clinical impact on the care of PH and are open to researchers in the U.S. and other countries with Team PHenomenal Hope presence — Belgium, Brazil, Germany, Mexico, and South Africa. Applicants should be within the first seven years after their fellowship, although exceptions may apply. Healthcare providers who are not medical doctors, such as registered nurses and doctors of pharmacy, are welcome to apply.
Applicants must submit letters of intent that include a CV, accompanied by prior work findings and project details. The letter should state how the research proposal “will transform the field of PH.”
The deadline for submitting letters of intent is Feb. 14. Short-listed finalists will be notified by Feb. 27, with full applications due March 31. Final proposals should be no longer than six pages with an extra page for a budget, budget justification, references, and a letter of support from a mentor, division chief, or collaborator. The winner will be notified in early May.
More information is available at [email protected] or by calling 877-646-4673, ext. 101. Applications are available online.
The proposals are evaluated by the organization’s Research Award Steering Committee, consisting of Harrison Farber, MD, Patricia George, MD, Raymond Benza MD, and Hunter Champion, MD.
Proposals will be evaluated for their scientific merit, originality, feasibility, and/or their clinical potential for diagnosing and treating PH patients.
In 2022, the Team PH Research Award was given to Arun Jose, MD, at the University of Cincinnati for his pulmonary arterial hypertension (PAH) proposal titled, “Circulating gut-derived metabolites as markers of disease severity in PAH.” His research focuses on identifying new PAH biomarkers as well as potential therapeutic targets. Nicole Ruopp, MD, was awarded in 2021 to support a clinical trial to test a mechanical circulatory device in PH.
About the Author
